Blockbuster TOKYO: Buzzreach Amongst 19 Teams Selected
Recently, Buzzreach has been selected as one of the team for “Blockbuster Tokyo”, an acceleration program specializing in drug discovery and medical ventures for contribution to raising awareness in clinical trials and closing the information gap regarding clinical trials information between patients and pharmaceutical companies as well as the development of patient-centred medical services. Operated by Beyond Next Ventures Inc. (Headquarters: Chuo-ku, Tokyo, President and CEO: Tsuyoshi Ito), 19 teams have been selected to participate in the 2019 selection program which will be held in October with the business plan presentation later in March 2020.
Beyond Next Ventures Inc.
Beyond Next Ventures Inc. is an independent accelerator that was established in August 2014 and specializes in investing in ventures that aims to innovate in the science and technology field. With the establishment of the No.1 and No. 2 funds in February 2015 and October 2018, the company has assets under management of a little less than 15 billion yen with an abundance of investment experience and excellent management results ranging from commercialization support of university seeds to investment and growth support. Over the years, they have developed various programs such as the “BRAVE Acceleration Program” which is a commercialization support program for researchers and entrepreneurs looking to commercialize cutting-edge technologies and “Blockbuster TOKYO”, which under the support of Tokyo Metropolitan Government aims to provide incubation funding for pharmaceutical and medical start-ups. In February 2019, a shared wet laboratory, “Beyond BioLab TOKYO” was established to provide commercialization support for life science start-ups. The most recent development is the provision of a co-founder matching platform “Co-founders” which will specialize in the creation of a strong founding team through real-world matching support for technology seeds and researchers at universities.
This time around they have implemented one of the largest technology-specific acceleration programs In Japan, “Blockbuster TOKYO”. This program provides various kinds of support to accelerate company growth which can be divided into two programs; a seminar program and an acceleration program. In the seminar program, seminars focusing on essential starting and expanding knowledge for pharmaceutical and medical start-ups will be held about once a month. Such seminars talk about venture related knowledge such as entrepreneurship, venture management, fund procurement and knowledge necessary for research and development (R & D) as well as business alliances. The acceleration program, on the other hand, provides more practical support for the teams with specific business plans. That is why there is a requirement for participants to take part in their seminar program prior to this program as they will be supported by necessary human resources that will specifically aid in the development of their plans including well-versed mentors in their respective field such as drug discovery, intellectual property, and marketing.
Please feel free to inquire using the form below. We will respond as soon as possible between 9:30 and 18:30 (Monday – Friday Japan Tokyo time).
Original media article: Published 04/10/2019, 19 teams selected for “Blockbuster TOKYO”, a training support program specializing in drug discovery and medical ventures
Retrieved from https://prtimes.jp/main/html/rd/p/000000060.000017460.html?fbclid=IwAR3Tehx9N1vq6o32idm7S3VMGLlJ9IfL076O35RkcqfRD7mVeg14lsKlYSw
1) Beyond Next Ventures Inc.: http://beyondnextventures.com
2) BRAVE Acceleration Program : http://brave.team
3) Blockbuster TOKYO : https://blockbuster.tokyo/en/home-en/
4) Beyond BioLAB TOKYO : http://biolab.beyondnextventures.com
5) Co-founders : https://co-founders.team